PBF-1129 (Palobiofarma)

N/A

Report date: 2024/11/25 20:00:28
NME

Base Information

Drug NamePBF-1129 (Palobiofarma)
Drug Alias NamePBF-1129
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsWounds and InjuriesDiabetes Mellitus, Type 2Diabetic Foot +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesChile
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPalobiofarma Sl
China Registration ClassN/A

Develop Information

Active CompaniesPalobiofarma Sl
Inactive CompaniesInstituto para el Desarrollo Biotecnológico y la Innovación SA
Active IndicationsIdiopathic Pulmonary FibrosisCarcinoma, Non-Small-Cell Lung
Inactive IndicationsWounds and InjuriesDiabetes Mellitus, Type 2Diabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A